Navigation Links
FDA's DDMAC Provides Insight on Pharmaceutical Companies and Web 2.0 in Eye on FDA Podcast
Date:3/17/2009

Eye on FDA, a specialty blog written by Mark Senak, Senior Vice President at Fleishman-Hillard in Washington, D.C., posts an interview with the new official at FDA's DDMAC in charge of Web 2.0 policy development providing insight into FDA's point of view about the use of New and Social Media in Web 2.0 by the pharmaceutical industry.

Washington, DC (PRWEB) March 17, 2009 -- Today Eye on FDA, a specialty blog written by Mark Senak, Senior Vice President at Fleishman-Hillard in Washington, D.C., posted a podcast recorded at the FDA on March 11, 2009 that interviews Dr. Jean Ah Kang, the official at FDA's DDMAC who is in charge of policy development with respect to pharmaceutical company use of new and social media in Web 2.0 marketing and communications efforts.

The pharmaceutical industry has been slow to embrace Web 2.0 because of regulatory concerns that reaching out to patients using social and digital media might provoke action by the FDA's Division of Drug Marketing Advertising and Communications (DDMAC). To date, the FDA has relied on traditional regulatory principles in evaluating pharmaceutical company use of Web 2.0 but has provided little insight on the agency's thinking of the many evolving communications in digital and social media.

Today, Eye on FDA posted Mark Senak's podcast interview with Dr. Jean Ah Kang, Special Assistant to DDMAC head Tom Abrams, who is in charge of the development of Web 2.0 policy for the FDA. They discussed whether or not the current regulatory environment prohibits pharmaceutical involvement in Web 2.0; what kind of considerations pharmaceutical companies need to consider; FDA's thoughts on specific situations involving social and digital media use; and how companies considering digital strategies should approach the FDA for input. It may well be the most complete public statement by the FDA on the topic to date.

Makr Senak's Eye on FDA

'Eye on FDA' has a diverse 'readership', including national media, government officials, patient groups, law firms, stock analysts and pharmaceutical companies themselves.

###

Read the full story at http://www.prweb.com/releases/fda-podcast-senak/32009/prweb2239614.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Related medicine news :

1. Study provides hope that some transplant patients could live free of antirejection drugs
2. Study provides hope that some transplant patients could live free of anti-rejection drugs
3. USAID Provides Additional Wildfire Assistance to Greece
4. LifeMasters Provides Tips for Maintaining a Healthy Blood Cholesterol Level
5. New knock-out gene model provides molecular clues to breast cancer
6. PreMD Provides Update on 510(k) Application for PREVU(x) POC
7. SIV infection of natural hosts provides new insights into HIV disease complexity
8. Microarray provides 3 genomic guides to breast cancer treatment decisions
9. Access Innovations Provides Support Services for Agis Network
10. Crdentias VP of Marketing, Christina Hogan, Provides Exclusive Interview on Marketing Strategy
11. Physical Therapist Provides Injury Analysis for Fantasy Football
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/20/2017)... ... January 20, 2017 , ... ATP Science, an Australian-based company ... attended the January ECRM Trade Show in Hilton Head, SC, benefiting from outstanding ... range of supplements that keep the body functioning at its peak performance by ...
(Date:1/20/2017)... ... January 20, 2017 , ... "TransFlare 4K Mystique comes ... of Final Cut Pro X," said Christina Austin - CEO of Pixel Film Studios. ... Utilizing the Dragon Sensor,TransFlare 4K Mystique lens flare and light leak transitions have a ...
(Date:1/20/2017)... ... January 20, 2017 , ... “The Angel”: a heartwarming and earnest ... for each of his children. “The Angel” is the creation of published author, Marjorie ... York City, and impassioned writer. , When asked of her new book, Marjorie says, ...
(Date:1/20/2017)... ... January 20, 2017 , ... D R ... Pressure (OPEP) device, was featured in a study indicating superior performance against competitive ... “Analysis of Three Oscillating Positive Expiratory Pressure Devices During Simulated Breathing“ was ...
(Date:1/20/2017)... ... ... “Knowledge is God’s Lighthouse”: a moving and colorful collection of prayers that reminds ... published author, Gene Gaapf, a retired truck driver, and a long-time writer, whose published ... high school and have many different titles,” Gaapf mentions about his different works. “I ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... ALTO, Calif. , Jan. 19, 2017   ... research, is excited to announce that the first ... Cancer Biology  (RP:CB) have been published in eLife ... this project represents the first practical evaluation of ... result in reproducible studies. Unlike other assessments of ...
(Date:1/19/2017)... 19, 2017 New Review ... Address Motor Symptoms and Motor Complications in Mid- ... ... (Logo: http://photos.prnewswire.com/prnh/20151014/276718LOGO) C ... Neurological Review,2016;11(Suppl. 2): 2-15, http://www.touchneurology.com/articles/safinamide-new-therapeutic-option-address-motor-symptoms-and-motor-complications-mid-late ...
(Date:1/19/2017)... global  pacemaker market  is expected to reach USD 12.3 billion by 2025, according ... cardiac conditions coupled with the availability of medical coverage is a key driving ... devices are supporting the expansion of this vertical. ... ... Logo ...
Breaking Medicine Technology: